Chemoinformaics analysis of 3-METHYLBUT-3-ENYL 3-METHYLBUTANOATE
| Molecular Weight | 170.252 | nRot | 5 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 6 |
| Exact Molecular Weight | 170.131 | nRing | 0 |
| Solubility: LogS | 0.475 | nHRing | 0 |
| Solubility: LogP | -1.148 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 30.3063 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.618 |
| Synth | 3.754 |
| Natural Product Likeliness | 2.217 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.157 |
| HIA | 0.728 |
| CACO-2 | -5.16 |
| MDCK | 0.000181833 |
| BBB | 0.344 |
| PPB | 0.110871 |
| VDSS | 0.672 |
| FU | 0.821317 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.543 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.603 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.023 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.158 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.146 |
| CL | 2.175 |
| T12 | 0.334 |
| hERG | 0.036 |
| Ames | 0.368 |
| ROA | 0.106 |
| SkinSen | 0.094 |
| Carcinogencity | 0.046 |
| EI | 0.024 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.940017 |